健康長壽與老化科學研究中心

Medicine & Life Sciences

1. Non-alcoholic Fatty Liver Disease 100%
2. Homeostasis 74%
3. Haploinsufficiency 73%
4. Sulfur 72%
5. Liver 57%
6. Iron 51%
7. Hepatocellular Carcinoma 47%
8. andrographolide 42%
9. Sodium Chloride Symporter Inhibitors 36%
10. Western Diet 36%
11. Severe Acute Respiratory Syndrome 35%
12. Longevity 34%
13. Coronavirus 34%
14. Metabolomics 33%
15. Proteomics 32%
16. Proteome 28%
17. Adipocytes 25%
18. Liver Diseases 25%
19. Peptide Hydrolases 22%
20. Oxidative Stress 22%
21. Cognitive Dysfunction 22%
22. Skeletal Muscle 21%
23. Alzheimer Disease 21%
24. Calcium 20%
25. Knockout Mice 19%
26. Wolfram Syndrome 17%
27. Wolfram Syndrome 2 17%
28. Hypertension 17%
29. Blood Pressure 17%
30. Hydrochlorothiazide 16%
31. Lipid Metabolism 13%
32. Proteins 13%
33. White Adipose Tissue 13%
34. Muscles 13%
35. Xenobiotics 11%
36. Genes 10%
37. Glucose 10%
38. Mitochondria 10%
39. Proteostasis 10%
40. Protein Domains 9%
41. Mitochondrial Membranes 9%
42. Chronic Disease 8%
43. Lysophosphatidylcholines 8%
44. Maintenance 7%
45. Fatty Liver 7%
46. Premature Aging 7%
47. Calcineurin 6%
48. Mitochondrial DNA 6%
49. Bile 6%
50. Adipogenesis 6%
51. Calcium Signaling 6%
52. Transgenic Mice 6%
53. Mammals 6%
54. Adiponectin 5%
55. Thiazides 5%
56. Endoplasmic Reticulum 5%
57. Therapeutics 5%
58. Middle Aged 5%
59. Fibrosis 5%
60. Membranes 5%

Chemical Compounds

1. Andrographolide 42%
2. Pharmacological Metabolism 35%
3. Drug Target 31%
4. Lipid 28%
5. Oxidative Stress 27%
6. Pump 26%
7. Metabolic 22%
8. Hydrogel 21%
9. Calcium(0) 20%
10. Modification 20%
11. Metabolite 19%
12. Biosynthesis 19%
13. Protein 17%
14. Cholesterol 12%
15. Fatty Acid 11%
16. Application 9%
17. Protein Synthesis 9%
18. Drug 9%
19. Fat 8%
20. Plasma 8%
21. Disorder 7%
22. Acrylamide 7%
23. Tryptophan 6%
24. Heterogeneity 6%
25. Shear Modulus 5%